A simple and rapid assay to evaluate purity of foot-and-mouth disease vaccine before animal experimentation.

[1]  Min-chul Kwon,et al.  Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea , 2017, The Journal of veterinary medical science.

[2]  Jian-liang Lv,et al.  Chemiluminescence Immunoassay for the Detection of Antibodies against the 2C and 3ABC Nonstructural Proteins Induced by Infecting Pigs with Foot-and-Mouth Disease Virus , 2017, Clinical and Vaccine Immunology.

[3]  K. Lee,et al.  Development and evaluation of an immunochromatographic assay using a gp51 monoclonal antibody for the detection of antibodies against the bovine leukemia virus , 2016, Journal of veterinary science.

[4]  Huizhi Guo,et al.  Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements , 2016, Virology Journal.

[5]  B. Pattnaik,et al.  Comparative evaluation of non-structural protein-antibody detecting ELISAs for foot-and-mouth disease sero-surveillance under intensive vaccination. , 2014, Journal of virological methods.

[6]  P. Daniels,et al.  Development and validation of a 3ABC antibody ELISA in Australia for foot and mouth disease. , 2014, Australian veterinary journal.

[7]  J. Pacheco,et al.  Domain disruptions of individual 3B proteins of foot-and-mouth disease virus do not alter growth in cell culture or virulence in cattle. , 2010, Virology.

[8]  A. Capozzo,et al.  Development of an in process control filtration-assisted chemiluminometric immunoassay to quantify foot and mouth disease virus (FMDV) non-capsid proteins in vaccine-antigen batches. , 2010, Vaccine.

[9]  C. del Rio,et al.  Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation. , 2010, Open access journal of clinical trials.

[10]  Nicole Fenwick,et al.  The welfare of animals used in science: how the "Three Rs" ethic guides improvements. , 2009, The Canadian veterinary journal = La revue veterinaire canadienne.

[11]  N. Mattion,et al.  Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. , 2008, Vaccine.

[12]  J. Oem,et al.  Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus. , 2007, Journal of virological methods.

[13]  M. Martín-Acebes,et al.  Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells. , 2006, Virology.

[14]  I. Bergmann,et al.  Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines. , 2006, Developments in biologicals.

[15]  B. Baxt,et al.  Foot-and-Mouth Disease , 2004, Clinical Microbiology Reviews.

[16]  K. Sorensen,et al.  Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus , 1998, Archives of Virology.

[17]  F. Sobrino,et al.  VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus , 1992, Journal of virology.

[18]  E. Wimmer,et al.  Systematic nomenclature of picornavirus proteins , 1984, Journal of virology.

[19]  N. Crawford,et al.  Genome-linked protein VPg of poliovirus is present as free VPg and VPg-pUpU in poliovirus-infected cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Rowlands,et al.  Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate , 1981, Journal of virology.